Cargando…

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of heart failure. Fortunately, the disease now has an approved therapy, with many others under development. Assessment of prognosis in ATTR-CM is critical to inform patients about the disease course and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Kent Y., Loungani, Rahul S., Rao, Vishal N., Patel, Chetan B., Khouri, Michel G., Felker, G. Michael, DeVore, Adam D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Primers in Cardio-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352120/ https://www.ncbi.nlm.nih.gov/pubmed/34396189 http://dx.doi.org/10.1016/j.jaccao.2019.11.006

Ejemplares similares

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020)

How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
por: Jacob, Robin, et al.
Publicado: (2021)

CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?
por: Ghosh, Arjun K., et al.
Publicado: (2020)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

CARTing Away Cardiac Fibrosis
por: Epstein, Jonathan A.
Publicado: (2020)

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
por: Witteles, Ronald M.
Publicado: (2021)

How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
por: Rubinstein, Samuel M., et al.
Publicado: (2021)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
por: Thuny, Franck, et al.
Publicado: (2022)

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
por: Huang, Yuhsin Vivian, et al.
Publicado: (2022)

How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations
por: Kambhampati, Swetha, et al.
Publicado: (2023)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
por: Minga, Iva, et al.
Publicado: (2023)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Rare association of left ventricular non-compaction and hypertrophic cardiomyopathy
por: Hotta, Viviane Tiemi, et al.
Publicado: (2020)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls
por: Tromp, Jasper, et al.
Publicado: (2020)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Palpitations in the Cancer Patient
por: Essa, Hani, et al.
Publicado: (2021)

Chest Pain in the Cancer Patient
por: Tyebally, Sara, et al.
Publicado: (2022)

Dyspnoea in Oncological Patients: A Brain Teaser
por: Keramida, Kalliopi, et al.
Publicado: (2023)

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
por: Peix, Amalia, et al.
Publicado: (2023)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
por: DeVries, J Hans, et al.
Publicado: (2023)

Diagnosis of Transthyretin Amyloid Cardiomyopathy
por: Hafeez, Adam S., et al.
Publicado: (2020)

Hereditary transthyretin amyloid cardiomyopathy
por: Zheng, Yiliang, et al.
Publicado: (2023)

Insights from multimodality imaging in a case of giant true coronary aneurysm treated percutaneously with polytetrafluoroethylene covered stent
por: Menahalli Palleda, Girish, et al.
Publicado: (2020)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
por: Rocha, Alexandre Marins, et al.
Publicado: (2017)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

How to select a best-value biological medicine? A practical model to support hospital pharmacists
por: Barbier, Liese, et al.
Publicado: (2022)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
por: Nakano, Tomoya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cj4rl40eagf083670uhatlot2t